The metabolic syndrome: A crossroad for genotype-phenotype associations in atherosclerosis

被引：24

作者：

Corella D. ^{[1
]}

Ordovas J.M. ^{[1
]}

机构：

[1] Nutrition and Genomics Laboratory, Department of Agriculture, Tufts University, Boston, MA 02111

来源：

Current Atherosclerosis Reports | 2004年 / 6卷 / 3期

基金：

美国国家卫生研究院;

关键词：

Metabolic Syndrome; Cholesteryl Ester Transfer Protein; Arterioscler Thromb Vasc Biol; Hepatic Lipase; Microsomal Triglyceride Transfer Protein;

D O I：

10.1007/s11883-004-0031-8

中图分类号：

学科分类号：

摘要：

The metabolic syndrome comprises a set of metabolic and physiologic risk factors associated with elevated cardiovascular disease risk. The expression of each one of its major factors (hypertriglyceridemia, low high-density lipoprotein cholesterol levels, hypertension, abdominal obesity, and insulin resistance) has been found to be the result of complex interactions between genetic and environmental factors. Moreover, obesity may play a major role in triggering the metabolic syndrome by interacting with genetic variants at candidate genes for dyslipidemia, hypertension, and insulin resistance. In support of this hypothesis, several studies at multiple candidate genes have already demonstrated the significance of these interactions; however, the data and their reliability are still very limited, and in many cases replication studies are still lacking in the literature. Therefore, more studies with better epidemiologic design and standardized adiposity measures are needed to estimate the contribution of body weight and fat distribution to the genetic predisposition to the metabolic syndrome, which is the most common cardiovascular disease risk factor in industrialized societies. Copyright © 2004 by Current Science Inc.

引用

页码：186 / 196

页数：10

共 67 条

[1]

Olden K., Wilson S., Environmental health and genomics: Visions and implications, Nat. Rev. Genet., 1, pp. 149-153, (2000)

[2]

Reaven G.M., Banting lecture 1988. Role of insulin resistance in human disease, Diabetes, 37, pp. 1595-1607, (1988)

[3]

Groop L., Orho-Melander M., The dysmetabolic syndrome, J. Intern. Med., 250, pp. 105-120, (2001)

[4]

Alberti K.G., Zimmet P.Z., Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation, Diabetes Med., 15, pp. 539-553, (1998)

[5]

Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III), JAMA, 285, pp. 2486-2497, (2001)

[6]

Ford E.S., Giles W.H., Dietz W.H., Prevalence of the metabolic syndrome among US adults: Findings from the third National Health and Nutrition Examination Survey, JAMA, 287, pp. 356-359, (2002)

[7]

Bonora E., Kiechl S., Willeit J., Et al., Metabolic syndrome: Epidemiology and more extensive phenotypic description. Cross-sectional data from the Bruneck Study, Int. J. Obes. Relat. Metab. Disord., 27, pp. 1283-1289, (2003)

[8]

Meigs J.B., Wilson P.W., Nathan D.M., Et al., Prevalence and characteristics of the metabolic syndrome in the San Antonio Heart and Framingham Offspring Studies, Diabetes, 52, pp. 2160-2167, (2003)

[9]

Ninomiya J.K., L'Italien G., Criqui M.H., Et al., Association of the metabolic syndrome with history of myocardial infarction and stroke in the third national health and nutrition examination survey, Circulation, 109, pp. 42-46, (2004)

[10]

Lakka H.M., Laaksonen D.E., Lakka T.A., Et al., The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men, JAMA, 288, pp. 2709-2716, (2002)

← 1 2 3 4 5 6 7 →